Evidence map›Paper›PMID 35898391›Full record

ArticleClinical Medicine Insights. Oncology2022

GRHL2 Expression Functions in Breast Cancer Aggressiveness and Could Serve as Prognostic and Diagnostic Biomarker for Breast Cancer.

Xiaoyu Bai, Yue Li, Yanlei Li, Fan Li, Na Che, Chunsheng Ni, Nan Zhao, Xiulan Zhao, Tieju Liu

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Clinical Medicine Insights. Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xiaoyu BaiDepartment of Pathology, Tianjin Medical University, Tianjin, China.
Yue LiDepartment of Pathology, Tianjin Medical University, Tianjin, China.
Yanlei LiDepartment of Pathology, Tianjin Medical University, Tianjin, China.
Fan LiDepartment of Pathology, Tianjin Medical University, Tianjin, China.
Na CheDepartment of Pathology, Tianjin Medical University, Tianjin, China.
Chunsheng NiDepartment of Pathology, Tianjin Medical University, Tianjin, China.
Nan ZhaoDepartment of Pathology, Tianjin Medical University, Tianjin, China.
Xiulan ZhaoDepartment of Pathology, Tianjin Medical University, Tianjin, China.
Tieju LiuDepartment of Pathology, Tianjin Medical University, Tianjin, China.ORCID https://orcid.org/0000-0003-4522-545X
Tianjin Medical University General Hospital · CNTianjin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Breast cancer (BC) is the most frequent malignancy in women worldwide and the leading cause of female cancer-associated death in the world. Grainyhead-like 2 ( Methods: In this study, we used in vitro experiments to verify the role of Results: At the cellular level, overexpression of Conclusions: In summary, evidence indicates that

Indexed as

breast cancerEMTGRHL2immunotherapytumour aggressiveness

Identifiers

PMID35898391
PMCPMC9310218
OpenAlexW4286374490

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.